In this study, we performed a comprehensive genomic analysis including whole exome sequencing (WES) and transcriptomic analysis of primary and recurrent tumor samples in both IDH-mutant and IDH-wildtype gliomas. This evidence concerns the gene IDH2 and central nervous system cancer.